Webster Bank N. A. Has $80,000 Stock Holdings in Aflac Incorporated (NYSE:AFL)

Webster Bank N. A. raised its position in Aflac Incorporated (NYSE:AFL) by 25.4% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 895 shares of the financial services provider’s stock after acquiring an additional 181 shares during the period. Webster Bank N. A.’s holdings in Aflac were worth $80,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Eudaimonia Partners LLC boosted its holdings in Aflac by 234.6% during the fourth quarter. Eudaimonia Partners LLC now owns 10,448 shares of the financial services provider’s stock valued at $862,000 after purchasing an additional 7,325 shares in the last quarter. Crossmark Global Holdings Inc. raised its stake in Aflac by 22.6% during the fourth quarter. Crossmark Global Holdings Inc. now owns 86,010 shares of the financial services provider’s stock worth $7,096,000 after acquiring an additional 15,855 shares in the last quarter. Southeast Asset Advisors Inc. raised its stake in Aflac by 0.4% during the fourth quarter. Southeast Asset Advisors Inc. now owns 139,164 shares of the financial services provider’s stock worth $11,481,000 after acquiring an additional 589 shares in the last quarter. Nordea Investment Management AB lifted its holdings in shares of Aflac by 6.7% during the first quarter. Nordea Investment Management AB now owns 1,806,475 shares of the financial services provider’s stock valued at $155,140,000 after acquiring an additional 113,226 shares during the period. Finally, Richard C. Young & CO. LTD. bought a new stake in shares of Aflac in the 4th quarter worth about $12,546,000. Institutional investors own 67.44% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on AFL. JPMorgan Chase & Co. lifted their price target on shares of Aflac from $80.00 to $83.00 and gave the company a “neutral” rating in a report on Tuesday, July 2nd. Wells Fargo & Company boosted their target price on Aflac from $81.00 to $82.00 and gave the stock an “equal weight” rating in a report on Friday, May 10th. Citigroup increased their price target on Aflac from $84.00 to $93.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 23rd. Truist Financial lifted their price objective on Aflac from $82.00 to $100.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Finally, Jefferies Financial Group decreased their target price on Aflac from $84.00 to $83.00 and set a “hold” rating on the stock in a report on Friday, June 28th. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and three have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $88.08.

Aflac Trading Up 0.3 %

Shares of AFL traded up $0.35 on Friday, reaching $101.21. 1,628,608 shares of the company’s stock were exchanged, compared to its average volume of 2,241,897. Aflac Incorporated has a 12 month low of $72.78 and a 12 month high of $104.90. The stock has a market capitalization of $57.51 billion, a P/E ratio of 11.17, a price-to-earnings-growth ratio of 2.76 and a beta of 0.95. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. The business has a 50 day moving average price of $91.92 and a two-hundred day moving average price of $86.26.

Aflac (NYSE:AFL) last posted its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.83 earnings per share for the quarter, beating analysts’ consensus estimates of $1.60 by $0.23. The company had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $4.10 billion. Aflac had a return on equity of 16.22% and a net margin of 28.35%. The firm’s quarterly revenue was down .7% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.58 EPS. Research analysts anticipate that Aflac Incorporated will post 6.48 earnings per share for the current year.

Aflac Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 2nd. Investors of record on Wednesday, August 21st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.98%. The ex-dividend date of this dividend is Wednesday, August 21st. Aflac’s dividend payout ratio is currently 22.08%.

Insider Buying and Selling at Aflac

In other news, Director Charles D. Lake II sold 22,378 shares of the business’s stock in a transaction on Tuesday, May 21st. The shares were sold at an average price of $87.47, for a total value of $1,957,403.66. Following the completion of the transaction, the director now owns 61,522 shares of the company’s stock, valued at approximately $5,381,329.34. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other news, Director Charles D. Lake II sold 22,378 shares of Aflac stock in a transaction dated Tuesday, May 21st. The stock was sold at an average price of $87.47, for a total transaction of $1,957,403.66. Following the transaction, the director now owns 61,522 shares in the company, valued at approximately $5,381,329.34. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Thomas J. Kenny sold 2,000 shares of the stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $98.94, for a total value of $197,880.00. Following the sale, the director now directly owns 18,158 shares of the company’s stock, valued at $1,796,552.52. The disclosure for this sale can be found here. Insiders own 0.90% of the company’s stock.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.